Drugs / Centella Asiatica Extract
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05017467 | Jan 2011 → Jan 2020 | keloid formation | Mustafa Balevi,MD | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03815305 | Jul 2018 → Jan 2019 | type 2 diabetes mellitus | Indonesia University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Centella Asiatica Extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05017467 ↗ |
| Route | Oral | “centlla asiatica oral drug at 1100 mg dose” NCT03815305 ↗ |